A new treatment option will soon be available to people with type 2 diabetes with the FDA’s approval on Friday of Invokana, a first-in-class medication to lower blood sugar.
eHealthcare Solutions (EHS) manages advertising on this website.
We use cookies to ensure that we give you the best experience on our website.
By continuing, you agree to the use of cookies as per the EHS Privacy Policy